Literature DB >> 3542546

Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.

G Fritsch, G Sawatzki, J Treumer, A Jung, D T Spira.   

Abstract

The microbial iron chelators desferriferrithiocin and desferricrocin as well as human lactoferrin were tested in vitro against Plasmodium falciparum. The microbial chelators inhibit the growth of P. falciparum in a dose dependent way. Parasite multiplication is stopped at 25-30 microM desferriferrithiocin, whereas 60-90 microM desferricrocin are needed to exhibit the same effect. After iron saturation, the microbial chelators are ineffective. Human lactoferrin (30 microM), both iron free and iron saturated, inhibits P. falciparum. A 3-day preincubation of host erythrocytes with iron free and iron saturated lactoferrin prior to infection enhances this effect, which is therefore attributed to lactoferrin bound iron. It has been suggested that the lactoferrin/iron complex generates oxygen free radicals, which may cause membrane damage of both erythrocyte and parasite. This process can be considered to lead to growth inhibition of the parasite.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3542546     DOI: 10.1016/0014-4894(87)90072-5

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  In vitro activities of novel catecholate siderophores against Plasmodium falciparum.

Authors:  B Pradines; F Ramiandrasoa; L K Basco; L Bricard; G Kunesch; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

2.  P. falciparum infected erythrocytes are capable of endocytosis.

Authors:  E R Burns; S Pollack
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

Review 3.  Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries.

Authors:  R Paesano; T Natalizi; F Berlutti; P Valenti
Journal:  Pathog Glob Health       Date:  2012-08       Impact factor: 2.894

4.  Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

Authors:  S R Meshnick; Y Z Yang; V Lima; F Kuypers; S Kamchonwongpaisan; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 5.  Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.

Authors:  Daniela Zarzosa-Moreno; Christian Avalos-Gómez; Luisa Sofía Ramírez-Texcalco; Erick Torres-López; Ricardo Ramírez-Mondragón; Juan Omar Hernández-Ramírez; Jesús Serrano-Luna; Mireya de la Garza
Journal:  Molecules       Date:  2020-12-08       Impact factor: 4.411

Review 6.  Activity of Apo-Lactoferrin on Pathogenic Protozoa.

Authors:  Magda Reyes-López; Gerardo Ramírez-Rico; Jesús Serrano-Luna; Mireya de la Garza
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

7.  Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.

Authors:  Marcela Parra; Xia Liu; Steven C Derrick; Amy Yang; Jinhua Tian; Kristopher Kolibab; Sanjai Kumar; Sheldon L Morris
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

8.  Killer bee molecules: antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium.

Authors:  Victoria Carter; Ann Underhill; Ibrahima Baber; Lakamy Sylla; Mounirou Baby; Isabelle Larget-Thiery; Agnès Zettor; Catherine Bourgouin; Ulo Langel; Ingrid Faye; Laszlo Otvos; John D Wade; Mamadou B Coulibaly; Sekou F Traore; Frederic Tripet; Paul Eggleston; Hilary Hurd
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

Review 9.  Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.

Authors:  Piera Valenti; Luigi Rosa; Daniela Capobianco; Maria Stefania Lepanto; Elisa Schiavi; Antimo Cutone; Rosalba Paesano; Paola Mastromarino
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.